| Previous Close | 0.153 |
| Open | 0.000 |
| Bid | 0.000 x 15000000 |
| Ask | 0.000 x 9000000 |
| Day's Range | 0.000 - 0.000 |
| 52 Week Range | |
| Volume | 500 |
| Avg. Volume | 6,462 |
| Market Cap | 46.981M |
| Beta (3Y Monthly) | -1.96 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.025 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Nutritional High International Inc. (“Nutritional High” or the “Company”) (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) is pleased to announce that it has completed a sale and leaseback financing of certain equipment located at its La Pine, Oregon facility (the “Equipment”) for gross proceeds of $438,407 USD to Veterans Capital Fund II, LP (the “Buyer” or “Veterans”). In addition, Nutritional High issued 156,574 common share purchase warrants (each, a “Warrant”) to the Buyer. Each Warrant entitles the Buyer to purchase one common share in the capital of the Company (a “Common Share”) at a price of $0.70 CDN per Common Shares for a period of 24 months from the date of issuance.
Nutritional High International Inc. ("Nutritional High" or the "Company") (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) wishes to provide comments on the results of the Midterm Elections and key regulatory developments in the US. US voters delivered a split verdict in midterm elections for Congress yesterday evening. The Democrats secured a majority in the House of Representatives while Republicans have further expanded their majority in the Senate.
Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) is pleased to provide an update on recent developments on operations in the state of Oregon. The Company has launched cannabis production in Oregon and successfully completed production of the first batch through the cold ethanol extraction equipment for laboratory testing. Nutritional High implements the highest standard in cannabis testing and production in order to cultivate high quality edibles and products for the Oregon adult-use market to align with all the other existing markets.
Nutritional High International Inc. (“Nutritional High” or the “Company”) (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) is pleased to announce that it has completed a sale and leaseback financing of certain equipment located at its FLI NorCal facility, located in Sacramento, California, and has leased other equipment to be delivered in short order (altogether, the “Equipment”) for gross proceeds of $741,127 USD. The sale and leaseback financing was provided by the Veterans Capital Corp. and ASC Lease Income, LLC (collectively, the “Buyer”). Pursuant to the agreement with the Buyer, the Company will utilize the Equipment to process a wide and expanding range of products under its FLÏ™ brand including Vape Pens, Syringes, Dab Jars and Mini Mints. Nutritional High distributes these products in the California market through the Company’s wholly owned Calyx Brands distributor.
Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) is pleased to announce the closing of the previously announced sale (the "Transaction") of its fifty percent (50%) membership interest (the “Membership Interest”) in Illinois-based NH Medicinal Dispensaries, LLC to ILDISP LLC, GTI-Clinic Illinois Holdings, LLC, a subsidiary of Green Thumb Industries Inc. and Ataraxia, LLC for an aggregate purchase price of USD$3,500,000. The net proceeds of the Transaction will be used by the Company towards expanding the business operations in California, Nevada, Oregon and Washington.
Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) is pleased to announce its wholly-owned subsidiary NH Medicinal Holdings, LLC (the “Seller”) has entered into a definitive agreement on October 19, 2018, to sell (the "Agreement") its fifty percent (50%) membership interest (the “Membership Interest”) of Illinois-based NH Medicinal Dispensaries, LLC to ILDISP LLC, GTI-Clinic Illinois Holdings, LLC (a subsidiary of Green Thumb Industries Inc. (“GTI”)) and Ataraxia, LLC, (collectively, the “Buyers”). In connection with the Agreement, the Buyers will acquire one hundred percent (100%) of the Sellers Membership Interest in NH Medicinal Dispensaries on closing for an aggregate purchase price of USD$3,500,000 in cash.
Nutritional High will work with Aura Health to outfit Aura with the knowledge and expertise to extract cannabis oil utilizing Nutritional High’s cryo ethanol process and other extraction methods. Aura will develop health and wellness products which, in turn, may be licensed to Nutritional High for distribution in the US. Jim Frazier, CEO of Nutritional High, commented, “The Nutritional High team is excited to announce this new venture with our long-time strategic partners, Aura Health.
NeutriSci International Inc. ("NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy® and Nutritional High International Inc. (“Nutritional High”) (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) are pleased to provide a further update on their previously announced partnership. The initial production run for the newly developed chewable, sublingual cannabis product (“NU Tablets”) for distribution and sale in the state of California, is on track and underway at Nutritional High's FLI NorCal facility in Sacramento, California. Delivery of the first purchase orders are set for November 2018. Initial distribution by Nutritional High's distributor, Calyx, will begin to approximately 450 plus dispensaries across the state of California. Unveiling of the finished packaging and branding will be released prior to the first shipment to dispensaries.
Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) is pleased to provide an update on its operations in California. The Company owns assets in multiple verticals in the California value chain including extraction through its subsidiary, Pasa Verde, LLC which operates its FLI NorCal production facility, and distribution through its subsidiary, Calyx Brands (“Calyx”). The Company is pleased to announce that Calyx has grown rapidly under Nutritional High’s leadership. Calyx has generated over USD $7.4 million in top line revenue and incurred approximately USD $6.1 million cost of sales in the six and a half months (March 15th, 2018, through September 30th, 2018) since it was acquired by the Company (see press release dated March 16th, 2018). In addition, Calyx services over 450 dispensaries covering the entire State.
TORONTO, Oct. 15, 2018 -- Nutritional High International Inc. (the “Company” or “Nutritional High”) (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) is pleased to announce the release.
Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) is pleased to announce that a settlement has been reached between Palo Verde LLC ("Palo Verde") and the Colorado Department of Revenue, Marijuana Enforcement Division (“MED”) regarding Palo Verde’s licensing status. The settlement is subject to final approval from Colorado’s State Licensing Authority (“State Licensing Authority”). Palo Verde operates a manufacturing facility in Pueblo, Colorado, which it leases from Nutritional High, and manufactures FLI-branded vape cartridges within the State.
TORONTO, Oct. 01, 2018 -- Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) is pleased to announce that it has.
Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) is pleased to announce that the Oregon Liquor Control Commission has granted a Marijuana Processor License to the Company’s wholly owned Nutritional High (Oregon) LLC, for its facility in La Pine, Oregon. The La Pine facility build out has been complete and the Company will immediately commence processing a wide range of products under the Nutritional High's FLI brand. Initial product offerings will include vape cartridges, syringes, and dab jars.
Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) is pleased to announce that Jim Frazier, CEO of Nutritional High, is scheduled to be a featured speaker at the Community-Led Cannabis Research Symposium hosted by the Cannabis Community Care and Research Network (C3RN). Frazier will be presenting about “FLÏ™ Products: Innovation in the Cannabis Industry,” a topic which allows for an opportunity for Nutritional High to illustrate its focus on product innovation, social responsibility and cannabis education.
Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) wishes to announce that at the September 6th, 2018, Annual and Special Meeting ("AGM") in Toronto, shareholders voted in favor of all items of business. Re-appointment of Davidson & Company LLP as auditors for the ensuing year and authorizing the directors to fix their remuneration. Davidson & Company LLP was first appointed as auditor of the company on July 11, 2018 and Change of Auditor documents were filed on SEDAR on July 18, 2018.
Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) is pleased to announce that operations have started at its "FLI Labs NorCal" manufacturing facility in Sacramento, California. FLI Labs NorCal, owned by the Company's wholly-owned subsidiary Pasa Verde LLC ("Pasa Verde"), will manufacture a wide range of products under Nutritional High's FLI brand. Initial product offering will include micro dosed press tabs, vape cartridges, syringes and dab jars.
Nutritional High International Inc. (the “Company” or “Nutritional High”) (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) would like to announce that it has filed a revised and restated Management’s Discussion and Analysis (“Revised MD&A”) as at, and for, the three and nine-month periods ended April 30th, 2018. The Ontario Securities Commission (the “OSC”), in connection with a staff review of the Company’s filings requested the below revisions to the Original MD&A. The Revised MD&A provides additional disclosures related to the Company’s operations in the United States cannabis industry and provides further guidance on the regulatory regimes of each of the Company’s respective states of operation.